Overall verdict
Neutral
5.3/10
1-year performance
+19.76%
Score breakdown
Up 19.8% over 1 year, 90% of the 52-week range.
Strongest: Profitability 6.7/10. Weakest: Financial strength 2.4/10.
13 analysts, target -0.0% vs the price.
Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other Operations. The company offers laboratory instruments, such as laboratory balances, liquid pipetting solutions, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, density and refractometry instruments, and thermal analysis systems ;
and other analytical instruments, including UV/VIS spectrophotometers, moisture analyzers, and cell counters, as well as LabX, a laboratory software platform to manage and analyze data generated by its instruments and automate workflows. It also provides industrial instruments comprising industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detectors, x-ray systems, checkweighers, and camera-based imaging equipment.
In addition, the company offers retail weighing solutions consisting of weighing and software solutions, AI-driven image recognition solutions for fresh goods, and automated packaging and labeling solutions for the meat backroom. The company serves pharmaceutical and biotech companies, independent research organizations, and testing labs ; food manufacturers and retailers ; chemical, specialty chemicals, and cosmetics companies ;
transportation and logistics, metals, and electronics industries ; and academic community through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is headquartered in Greifensee, Switzerland.
Sector
Health Care
Industry
Life Sciences Tools and Services
Primary listing
Nyse
United States
CEO
Patrick Kaltenbach
Founded
1991
Employees
18 100
Revenue / employee
222 453 USD
Next earnings
February 4, 2027 (estimated)
Institutional holders
- GEODE CAPITAL MANAGEMENT, LLC2.74%
- Bank of New York Mellon Corp1.47%
- FMR LLC1.16%
- Rest of the register94.63%
3 13F filings as of September 30, 2026: US managers above $100M, filed up to 45 days after quarter end. No insiders, no retail. A share on loan is declared by its lender and by whoever bought it from the short seller, so the total can exceed 100%.
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
1806.58 USD
52-week low
1023.05 USD
1-year performance
19.76%
Rising
Year-to-date performance
23.59%
Rising
Drawdown
-4.31%
Near its high
Position in the 52-week range
90% of range
Against the world ETF
Over 26 years, from December 2000 to October 2026, the share did better than the world ETF once risk is accounted for.
$10,000 placed at the end of December 2000 are worth today
| Mettler-Toledo | $308,011 |
| World ETF | $65,117 |
| S&P 500 | $91,204 |
| Risk-free placement | $15,894 |
The risk
- Shaking:the share moves 1.9 times as much as the world ETF.
- Worst fall:-56 % between November 2007 and March 2009. $10,000 placed at the top fell to $4,411. The world ETF, at worst: -53 %. Back to its high in 13 months.
Mettler-Toledo earned 5 times as much as the world ETF since 2000
Value of $10,000 placed at the end of December 2000, dividends reinvested, in dollars
- Mettler-Toledo: $308,011
- World ETF: $65,117
- S&P 500: $91,204
- Risk-free placement: $15,894
Based on past performance. This is not a recommendation.
Range: 1087.93 USD - 1253.93 USD (comparables only)
The price implies growth of 13.90% per year; the company grows at 11.04%.
Gross margin 58.5%, net margin 22.2%, ROIC 47.4%, ROE -1089.1%.
Net margin
22.25%
Exceptional
Sector 3.88%|S&P 13.40%
Gross margin
58.54%
Exceptional
Return on equity (ROE)
-1089.06%
Negative
Sector 3.52%|S&P 17.06%
Return on invested capital (ROIC)
47.44%
Exceptional
Free cash flow margin (FCF)
20.74%
Exceptional
Profit-to-cash conversion (FCF conversion)
0.93x
High
Margin stability
2.8 pts
Steady
Revenue to net income
Growth
6.1/10Revenue up 6.3% over 1 year, 5.5% a year over 5, EPS 11.0% a year over 5.
Revenue (trailing 12 months)
4.2Md USD
Revenue growth (1y)
6.27%
Solid
Revenue growth (3y)
2.72%
Moderate
EPS growth (1y)
16.21%
Solid
EPS CAGR (5y)
11.04%
Fair
EPS revisions (3 months)
1.00%
Revised up
Valuation
3.7/10P/E 37.5x, forward P/E 37.0x, EV/EBITDA 27.3x, PEG 3.39. The multiple sits in the 85th percentile of its own 5-year history.
P/E (TTM)
37.5x
Fair
Sector 50.5x|S&P 23.6x
Forward P/E
37.0x
Expensive
EV / EBITDA
27.3x
Expensive
Sector 22.4x|S&P 15.5x
PEG
3.39
Very expensive
Sector 1.25|S&P 0.91
Fair value (reverse DCF)
1170.93 USD
Deeply overvalued
P/E vs its own 5-year history
among the 15% highest valuations
At its historical high
Market cap
34.4Md USD
Financial strength
2.4/10Cash covers 2.6% of the debt, net debt/EBITDA 1.8x.
Net debt / EBITDA
1.8x
Stretched
Gearing (net debt / equity)
2538.53%
Stretched
Cash
52.2M USD
Cash / market cap
0.15%
Stretched
Cash / total debt
2.58%
Stretched
Interest coverage
16.9x
Very solid
Net debt
2.0Md USD
Equity
77.7M USD
Closed daily candles, 2 years
Last close on November 10, 2026: 1,751.38 USD
- MM201,681.22
- MM501,538.22
- MM2001,347.19
- RSI 1467.8
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
+1.84%
200-day average slope, 3 months
+1.95%
50-day average slope, 1 month
+7.66%
Price structure
higher-low
Bullish RSI divergence
No
20-day volatility
1.43 % per day
Volatility change
-27.91%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2026 | 46.78 (6) | 47.82 (13) | 4 264 (11) | 1 343 (9) | 937 (3) |
| 2027 | 51.94 (6) | 53.22 (13) | 4 451 (12) | 1 432 (9) | 1 015 (3) |
Amounts in millions of USD, EPS in USD per share. In brackets, the number of analysts. Consensus as of November 11, 2026.
Same sub-industry: 104 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 603259 | 8.7 | 8.2 | 68.4Md USD | — | — | 70.5 % | — | -1.7x | — | 62.1 % | ||
| 2 | IQV | 7.3 | 6.9 | 45.2Md USD | 33.4x | 8.1 % | 8.0 % | 6.8 % | 4.1x | 4.6 % | 28.0 % | ||
| 3 | A207940 | 7.1 | 7.0 | 52.5Md USD | 39.7x | 41.1 % | -10.2 % | — | -0.2x | — | -24.4 % | ||
| 4 | A | 6.5 | 6.0 | 49.9Md USD | 34.8x | 19.5 % | 8.1 % | 13.9 % | 0.9x | 2.5 % | 20.4 % | ||
| 5 | DHR | 6.5 | 6.4 | 166Md USD | 38.5x | 16.7 % | 8.3 % | 5.9 % | 2.0x | 3.5 % | 11.5 % | ||
| 6 | TMO | 6.2 | 5.5 | 266Md USD | 37.9x | 14.9 % | 9.1 % | 8.0 % | 2.8x | 2.9 % | 24.6 % | ||
| 7 | LONN | 5.6 | 4.7 | 54.1Md USD | Not meaningful (loss) | 16.7 % | 19.2 % | 8.7 % | 1.9x | 0.5 % | 22.7 % | ||
| 8 | MTD | 5.3 | 4.9 | 34.4Md USD | 37.5x | 22.2 % | 6.3 % | 47.4 % | 1.8x | 2.5 % | 19.8 % | ||
| 9 | WAT | 4.3 | 1.7 | 46.3Md USD | 202.3x | 1.8 % | 120.9 % | 0.8 % | 0.8x | 0.6 % | 23.9 % |
